| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.052 | 0.07 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.067 | 0.07 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.057 | 0.07 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | -0.068 | 0.07 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.064 | 0.07 |
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | 0.06 | 0.08 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.092 | 0.08 |
| mRNA | AA-COCF3 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.08 |
| mRNA | S-Trityl-L-cysteine | FIMM | pan-cancer | AAC | -0.34 | 0.08 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | 0.06 | 0.08 |